Credit Suisse raises target, EPS on Torrent Pharma

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Moneycontrol Bureau Credit Suisse has increased target price of Torrent Pharma to Rs 1450 per share and also raised FY16/17 earnings per share (EPS) by 12/7 percent. The brokerage says higher Abilify sales, Dahej addressing capacity constraints and 10 percent price increase in Elder portfolio are key. According to Credit Suisse important markets of Torrent Pharma in order of priority are India, the US, Brazil and Germany.After a meeting with management, the brokerage says execution has improved (India), growth investment has picked up sharply, focus is on fewer markets (exited 20 countries in emerging markets) and risk appetite has increased. “Dahej plant commissioning will address capacity constraints for the US and EU. Elder integration is running a year ahead of targets. Torrent aims to reach USD 500 million in sales in the US by 2020 and plans to step up ANDA filings from FY17 onwards to 18-20 annually,” it says in a note. Torrent Pharmaceuticals was quoting at Rs 1470, down Rs 14.00, or 0.94 percent on the BSE. Posted by Nasrin Sultana Follow @NasrinzStory